AI Verdict
HQY has stronger fundamentals based on our AI analysis.
HROW vs HQY Fundamental Comparison
| Metric | HROW | HQY |
|---|---|---|
| Revenue | $272.3M | $1.3B |
| Net Income | $-5.1M | $215.2M |
| Net Margin | -1.9% | 16.4% |
| ROE | -9.8% | 10.2% |
| ROA | -1.3% | 6.4% |
| Current Ratio | 2.20x | 3.27x |
| Debt/Equity | 4.77x | 0.45x |
| EPS | $-0.14 | $2.46 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
HROW vs HQY: Frequently Asked Questions
Is HROW or HQY a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), HQY has stronger fundamentals. HROW is rated HOLD (68% confidence) while HQY is rated BUY (82% confidence). This is not investment advice.
How does HROW compare to HQY fundamentally?
HARROW, INC. has ROE of -9.8% vs HEALTHEQUITY, INC.'s 10.2%. Net margins are -1.9% vs 16.4% respectively.
Which stock pays higher dividends, HROW or HQY?
HROW has a dividend yield of N/A or no dividend while HQY has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in HROW or HQY for long term?
For long-term investing, consider that HROW has HOLD rating with 68% confidence, while HQY has BUY rating with 82% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about HROW vs HQY?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For HROW vs HQY, the AI consensus favors HQY based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.